Lv1
60 积分 2025-07-03 加入
Development of PD-L1 Targeting Small-Molecule Immunotheranostic Agents for Personalized Antitumor Immunotherapy
27天前
已完结
Abstract 3139: The novel peptide drug conjugate AVA6103 is a FAP-enabled pre|CISION® medicine which targets exatecan, a topoisomerase I inhibitor, to the tumor microenvironment following FAP cleavage
4个月前
已完结
Abstract 1411: LAMC2 promotes progression and gemcitabine resistance through modulation of EMT and ATP-binding transporters in pancreatic ductal adenocarcinoma
6个月前
已关闭
In silico design and preclinical evaluation of a novel Trop2-targeted peptide tracer for PET imaging of tumors
6个月前
已完结
Pharmacological targeting of the receptor ALK inhibits tumorigenicity and overcomes chemoresistance in pancreatic ductal adenocarcinoma
7个月前
已完结
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
7个月前
已完结
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
7个月前
已完结
LAMC2 regulates the proliferation, invasion, and metastasis of gastric cancer via PI3K/Akt signaling pathway
7个月前
已完结
Oxaliplatin induces immunogenic cells death and enhances therapeutic efficacy of checkpoint inhibitor in a model of murine lung carcinoma
7个月前
已完结
皖公网安备34019202002308
